ONC Nurse (cn.com/home CME Information)

Article

Integrating Genetics and Genomics Into Oncology Nursing March 1, 2010 By Dale Halsey Lea, MPH, RN, CGC, FAAN Health Educator, National Human Genome Research Institute

Integrating Genetics and Genomics Into Oncology Nursing
March 1, 2010
By Dale Halsey Lea, MPH, RN, CGC, FAAN
Health Educator, National Human Genome Research Institute


This activity is based on articles and reports in ONCOLOGY Nurse Edition. It is developed from an identified educational need for information about practical management issues in medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC.
 

CME, 1.0 Credits
Hosted on cmellc.com

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.